The Immunomodulatory Functions of Butyrate

References

• Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14. doi:10.3390/microorganisms7010014
   PubMed Web of Science ®Google Scholar
• Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. doi:10.1038/nature11234
   PubMed Web of Science ®Google Scholar
• Kapourchali FR, Cresci GAM. Early-life gut microbiome-The importance of maternal and infant factors in its establishment. Nutr Clin Pract. 2020;35(3):386–405. doi:10.1002/ncp.10490
   PubMed Web of Science ®Google Scholar
• Cresci GA, Bawden E. Gut microbiome. Nutr Clin Pract. 2015;30(6):734–746. doi:10.1177/0884533615609899
   PubMed Web of Science ®Google Scholar
• Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the human gut microbiome: an international review. Dig Dis Sci. 2020;65(3):723–740. doi:10.1007/s10620-020-06112-w
   PubMed Web of Science ®Google Scholar
• Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14.
   PubMed Web of Science ®Google Scholar
• Bandeira A, Mota-Santos T, Itohara S, et al. Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med. 1990;172(1):239–244. doi:10.1084/jem.172.1.239
   PubMed Web of Science ®Google Scholar
• McDermott AJ, Huffnagle GB. The microbiome and regulation of mucosal immunity. Immunology. 2014;142(1):24–31. doi:10.1111/imm.12231
   PubMed Web of Science ®Google Scholar
• Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol. 2003;4(3):269–273. doi:10.1038/ni888
   PubMed Web of Science ®Google Scholar
• Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17(12):1519–1528. doi:10.3748/wjg.v17.i12.1519
   PubMed Web of Science ®Google Scholar
• Riviere A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016;7:979. doi:10.3389/fmicb.2016.00979
   PubMed Web of Science ®Google Scholar
• Garcia-Miguel M, Gonzalez MJ, Quera R, Hermoso MA. Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa. Biomed Res Int. 2013;2013:142492. doi:10.1155/2013/142492
   PubMed Web of Science ®Google Scholar
• Lazar V, Ditu LM, Pircalabioru GG, et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018;9:1830. doi:10.3389/fimmu.2018.01830
   PubMed Web of Science ®Google Scholar
• Goncalves P, Martel F. Regulation of colonic epithelial butyrate transport: focus on colorectal cancer. Porto Biomed J. 2016;1(3):83–91. doi:10.1016/j.pbj.2016.04.004
   PubMedGoogle Scholar
• Roychowdhury S, Glueck B, Han Y, Mohammad MA, Cresci GAM. A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice. Nutrients. 2019;11(1):97.
   PubMed Web of Science ®Google Scholar
• Cresci GA, Thangaraju M, Mellinger JD, Liu K, Ganapathy V. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J Gastrointest Surg. 2010;14(3):449–461. doi:10.1007/s11605-009-1045-x
   PubMed Web of Science ®Google Scholar
• Parada Venegas D, De la Fuente MK, Landskron G, et al. Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277. doi:10.3389/fimmu.2019.00277
   PubMed Web of Science ®Google Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16:461–478.
   PubMed Web of Science ®Google Scholar
• Bachmann C, Colombo JP, Berüter J. Short chain fatty acids in plasma and brain: quantitative determination by gas chromatography. Clin Chim Acta. 1979;92(2):153–159. doi:10.1016/0009-8981(79)90109-8
   PubMed Web of Science ®Google Scholar
• Liu L, Li L, Min J, et al. Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cell Immunol. 2012;277(1–2):66–73. doi:10.1016/j.cellimm.2012.05.011
   PubMed Web of Science ®Google Scholar
• Velázquez OC, Lederer HM, Rombeau JL. Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Adv Exp Med Biol. 1997;427:123–134.
   PubMed Web of Science ®Google Scholar
• Dass NB, John AK, Bassil AK, et al. The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil. 2007;19(1):66–74. doi:10.1111/j.1365-2982.2006.00853.x
   PubMed Web of Science ®Google Scholar
• Cherbut C, Ferrier L, Rozé C, et al. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol. 1998;275:G1415–G1422.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Tatewaki M, Yamada T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol. 2003;284(5):R1269–R1276. doi:10.1152/ajpregu.00442.2002
   PubMed Web of Science ®Google Scholar
• Lee C, Kim BG, Kim JH, Chun J, Im JP, Kim JS. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. Int Immunopharmacol. 2017;51:47–56. doi:10.1016/j.intimp.2017.07.023
   PubMed Web of Science ®Google Scholar
• Agus A, Denizot J, Thevenot J, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent-invasive E. coli infection and intestinal inflammation. Sci Rep. 2016;6:19032.
   PubMed Web of Science ®Google Scholar
• Ang Z, Er JZ, Ding JL. The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes. Sci Rep. 2015;5(1):8134. doi:10.1038/srep08134
   PubMedGoogle Scholar
• Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278(13):11312–11319. doi:10.1074/jbc.M211609200
   PubMed Web of Science ®Google Scholar
• Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111(6):2247–2252. doi:10.1073/pnas.1322269111
   PubMed Web of Science ®Google Scholar
• Cox MA, Jackson J, Stanton M, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol. 2009;15(44):5549–5557. doi:10.3748/wjg.15.5549
   PubMed Web of Science ®Google Scholar
• Nastasi C, Candela M, Bonefeld CM, et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 2015;5(1):16148. doi:10.1038/srep16148
   PubMedGoogle Scholar
• Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40(1):128–139. doi:10.1016/j.immuni.2013.12.007
   PubMed Web of Science ®Google Scholar
• Thangaraju M, Cresci GA, Liu K, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69(7):2826–2832. doi:10.1158/0008-5472.CAN-08-4466
   PubMed Web of Science ®Google Scholar
• Tunaru S, Kero J, Schaub A, et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med. 2003;9(3):352–355. doi:10.1038/nm824
   PubMed Web of Science ®Google Scholar
• Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013;145(2):396–406 e391–310. doi:10.1053/j.gastro.2013.04.056
   Web of Science ®Google Scholar
• Bhatt B, Zeng P, Zhu H, et al. Gpr109a limits microbiota-induced IL-23 production to constrain ILC3-mediated colonic inflammation. J Immunol. 2018;200(8):2905–2914. doi:10.4049/jimmunol.1701625
   PubMed Web of Science ®Google Scholar
• Gong Y, Jin X, Yuan B, et al. G protein-coupled receptor 109A maintains the intestinal integrity and protects against ETEC mucosal infection by promoting IgA secretion. Front Immunol. 2020;11:583652. doi:10.3389/fimmu.2020.583652
   PubMed Web of Science ®Google Scholar
• Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther. 2016;164:144–151. doi:10.1016/j.pharmthera.2016.04.007
   PubMed Web of Science ®Google Scholar
• Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667–685.
   PubMed Web of Science ®Google Scholar
• Cresci GA, Bush K, Nagy LE. Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol Clin Exp Res. 2014;38(6):1489–1501. doi:10.1111/acer.12428
   PubMed Web of Science ®Google Scholar
• Cresci GA, Glueck B, McMullen MR, Xin W, Allende D, Nagy LE. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol. 2017;32(9):1587–1597. doi:10.1111/jgh.13731
   PubMed Web of Science ®Google Scholar
• Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009;139(9):1619–1625. doi:10.3945/jn.109.104638
   PubMed Web of Science ®Google Scholar
• Nielsen DSG, Jensen BB, Theil PK, Nielsen TS, Knudsen KEB, Purup S. Effect of butyrate and fermentation products on epithelial integrity in a mucus-secreting human colon cell line. J Funct Foods. 2018;40:9–17. doi:10.1016/j.jff.2017.10.023
   Web of Science ®Google Scholar
• Feng Y, Wang Y, Wang P, Huang Y, Wang F. Short-Chain Fatty Acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cell Physiol Biochem. 2018;49(1):190–205. doi:10.1159/000492853
   PubMedGoogle Scholar
• Elamin EE, Masclee AA, Dekker J, Pieters HJ, Jonkers DM. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J Nutr. 2013;143(12):1872–1881. doi:10.3945/jn.113.179549
   PubMed Web of Science ®Google Scholar
• Kelly CJ, Zheng L, Campbell EL, et al. Crosstalk between microbiota-derived Short-Chain Fatty Acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17(5):662–671. doi:10.1016/j.chom.2015.03.005
   PubMed Web of Science ®Google Scholar
• Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;61(1):37–41. doi:10.1203/01.pdr.0000250014.92242.f3
   PubMed Web of Science ®Google Scholar
• Bach knudsen KE, Lærke HN, Hedemann MS, et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients. 2018;10(10):1499.
   PubMed Web of Science ®Google Scholar
• Burgueno JF, Abreu MT. Epithelial toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020;17(5):263–278. doi:10.1038/s41575-019-0261-4
   PubMed Web of Science ®Google Scholar
• Elce A, Amato F, Zarrilli F, et al. Butyrate modulating effects on pro-inflammatory pathways in human intestinal epithelial cells. Benef Microbes. 2017;8(5):841–847. doi:10.3920/BM2016.0197
   PubMed Web of Science ®Google Scholar
• Andoh A, Bamba T, Sasaki M. Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. J Parenter Enteral Nutr. 1999;23(5_suppl):S70–S73. doi:10.1177/014860719902300518
   PubMed Web of Science ®Google Scholar
• Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn’s disease. Gut. 2000;47(3):397–403. doi:10.1136/gut.47.3.397
   PubMed Web of Science ®Google Scholar
• Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J. 2006;82(964):130–135. doi:10.1136/pgmj.2005.037945
   PubMed Web of Science ®Google Scholar
• Chen G, Ran X, Li B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317–325. doi:10.1016/j.ebiom.2018.03.030
   PubMed Web of Science ®Google Scholar
• Kinoshita M, Suzuki Y, Saito Y. Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation. Biochem Biophys Res Commun. 2002;293(2):827–831. doi:10.1016/S0006-291X(02)00294-2
   PubMed Web of Science ®Google Scholar
• Li M, van Esch B, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018;831:52–59. doi:10.1016/j.ejphar.2018.05.003
   PubMed Web of Science ®Google Scholar
• Glueck B, Han Y, Cresci GAM. Tributyrin supplementation protects immune responses and vasculature and reduces oxidative stress in the proximal colon of mice exposed to chronic-binge ethanol feeding. J Immunol Res. 2018;2018:9671919. doi:10.1155/2018/9671919
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen F, Wu W, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11(3):752–762. doi:10.1038/mi.2017.118
   PubMed Web of Science ®Google Scholar
• Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun. 2002;70(2):953–963. doi:10.1128/IAI.70.2.953-963.2002
   PubMed Web of Science ®Google Scholar
• Schulthess J, Pandey S, Capitani M, et al. The Short Chain Fatty Acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019;50(2):432–445 e437. doi:10.1016/j.immuni.2018.12.018
   PubMed Web of Science ®Google Scholar
• Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22(9):849–855. doi:10.1016/j.jnutbio.2010.07.009
   PubMed Web of Science ®Google Scholar
• Sina C, Gavrilova O, Förster M, et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009;183(11):7514–7522. doi:10.4049/jimmunol.0900063
   PubMed Web of Science ®Google Scholar
• Vinolo MA, Ferguson GJ, Kulkarni S, et al. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One. 2011;6(6):e21205. doi:10.1371/journal.pone.0021205
   PubMed Web of Science ®Google Scholar
• Rodrigues HG, Takeo sato F, Curi R, Vinolo MAR. Fatty acids as modulators of neutrophil recruitment, function and survival. Eur J Pharmacol. 2016;785:50–58.
   PubMed Web of Science ®Google Scholar
• Aoyama M, Kotani J, Usami M. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition. 2010;26(6):653–661. doi:10.1016/j.nut.2009.07.006
   PubMed Web of Science ®Google Scholar
• Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol. 2012;67(5):391–400. doi:10.1111/j.1600-0897.2011.01089.x
   PubMed Web of Science ®Google Scholar
• Bailón E, Cueto-Sola M, Utrilla P, et al. Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology. 2010;215(11):863–873. doi:10.1016/j.imbio.2010.01.001
   PubMed Web of Science ®Google Scholar
• Kraneveld AD, Sagar S, Garssen J, Folkerts G. The two faces of mast cells in food allergy and allergic asthma: the possible concept of Yin Yang. Biochim Biophys Acta Mol Basis Dis. 2012;1822(1):93–99. doi:10.1016/j.bbadis.2011.06.013
   PubMed Web of Science ®Google Scholar
• Bischoff SC. Mast cells in gastrointestinal disorders. Eur J Pharmacol. 2016;778:139–145. doi:10.1016/j.ejphar.2016.02.018
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 1996;28(1):1–13. doi:10.1046/j.1365-2559.1996.262309.x
   PubMed Web of Science ®Google Scholar
• Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W. Strictures in Crohn’s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut. 1999;45(2):210–217. doi:10.1136/gut.45.2.210
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Vuillermin PJ, et al. Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways. Cell Rep. 2016;15(12):2809–2824. doi:10.1016/j.celrep.2016.05.047
   PubMed Web of Science ®Google Scholar
• Hung TV, Suzuki T. Dietary fermentable fiber reduces intestinal barrier defects and inflammation in colitic mice. J Nutr. 2016;146(10):1970–1979. doi:10.3945/jn.116.232538
   PubMed Web of Science ®Google Scholar
• Araki Y, Kanauchi O, Sugihara H, Fujiyama Y, Hattori T. Germinated barley foodstuff suppresses dextran sulfate experimental colitis in rats: the role of mast cells. Int J Mol Med. 2007;19:257–262.
   PubMed Web of Science ®Google Scholar
• Kanauchi O, Mitsuyama K, Homma T, et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med. 2003;12:701–704.
   PubMed Web of Science ®Google Scholar
• Hanai H, Kanauchi O, Mitsuyama K, et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med. 2004;13:643–647.
   PubMed Web of Science ®Google Scholar
• Wang CC, Wu H, Lin FH, et al. Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs. Innate Immun. 2018;24(1):40–46. doi:10.1177/1753425917741970
   PubMed Web of Science ®Google Scholar
• Diakos C, Prieschl EE, Saemann MD, et al. n-butyrate inhibits Jun NH(2)-terminal kinase activation and cytokine transcription in mast cells. Biochem Biophys Res Commun. 2006;349(2):863–868. doi:10.1016/j.bbrc.2006.08.117
   PubMed Web of Science ®Google Scholar
• Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517(7534):293–301. doi:10.1038/nature14189
   PubMed Web of Science ®Google Scholar
• Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722–725. doi:10.1038/nature07537
   PubMed Web of Science ®Google Scholar
• Kim SH, Cho BH, Kiyono H, Jang YS. Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer’s patches. Sci Rep. 2017;7(1):3980. doi:10.1038/s41598-017-02729-6
   PubMed Web of Science ®Google Scholar
• Yang W, Yu T, Huang X, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457. doi:10.1038/s41467-020-18262-6
   PubMed Web of Science ®Google Scholar
• Zenewicz LA. IL-22: there is a gap in our knowledge. Immunohorizons. 2018;2(6):198–207. doi:10.4049/immunohorizons.1800006
   PubMedGoogle Scholar
• Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50:871–891.
   PubMed Web of Science ®Google Scholar
• Millard AL, Mertes PM, Ittelet D, Villard F, Jeannesson P, Bernard J. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol. 2002;130(2):245–255. doi:10.1046/j.0009-9104.2002.01977.x
   PubMed Web of Science ®Google Scholar
• Gurav A, Sivaprakasam S, Bhutia YD, Boettger T, Singh N, Ganapathy V. Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions. Biochem J. 2015;469(2):267–278. doi:10.1042/BJ20150242
   PubMed Web of Science ®Google Scholar
• Nastasi C, Fredholm S, Willerslev-Olsen A, et al. Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells. Sci Rep. 2017;7(1):14516. doi:10.1038/s41598-017-15099-w
   PubMedGoogle Scholar
• Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504(7480):451–455. doi:10.1038/nature12726
   PubMed Web of Science ®Google Scholar
• Correa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 2016;5(4):e73. doi:10.1038/cti.2016.17
   PubMedGoogle Scholar
• Steinman RM. Linking innate to adaptive immunity through dendritic cells. Novartis Found Symp. 2006;279:101–109;discussion 109–113, 216–109.
   PubMedGoogle Scholar
• Nam JH, Lee JH, Choi SY, et al. Functional ambivalence of dendritic cells: tolerogenicity and immunogenicity. Int J Mol Sci. 2021;22(9):4430.
   PubMed Web of Science ®Google Scholar
• Kaisar MMM, Pelgrom LR, van der Ham AJ, Yazdanbakhsh M, Everts B. butyrate conditions human dendritic cells to prime type 1 regulatory T cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling. Front Immunol. 2017;8:1429. doi:10.3389/fimmu.2017.01429
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–450. doi:10.1038/nature12721
   PubMed Web of Science ®Google Scholar
• Kespohl M, Vachharajani N, Luu M, et al. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells. Front Immunol. 2017;8:1036. doi:10.3389/fimmu.2017.01036
   PubMed Web of Science ®Google Scholar
• Luu M, Weigand K, Wedi F, et al. Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate. Sci Rep. 2018;8(1):14430. doi:10.1038/s41598-018-32860-x
   PubMedGoogle Scholar
• Trompette A, Gollwitzer ES, Pattaroni C, et al. Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism. Immunity. 2018;48(5):992–1005 e1008. doi:10.1016/j.immuni.2018.04.022
   PubMed Web of Science ®Google Scholar
• Bachem A, Makhlouf C, Binger KJ, et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8(+) T cells. Immunity. 2019;51(2):285–297 e285. doi:10.1016/j.immuni.2019.06.002
   PubMed Web of Science ®Google Scholar
• Ji L, Hu X. Sweet memories of 8 empowered by butyrate. Immunity. 2019;51(2):201–203. doi:10.1016/j.immuni.2019.07.005
   PubMed Web of Science ®Google Scholar
• Sun M, Wu W, Chen L, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9(1):3555. doi:10.1038/s41467-018-05901-2
   PubMed Web of Science ®Google Scholar
• Kim DS, Woo JS, Min HK, et al. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjogren’s syndrome. J Autoimmun. 2021;119:102611. doi:10.1016/j.jaut.2021.102611
   PubMed Web of Science ®Google Scholar
• Rosser EC, Piper CJM, Matei DE, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab. 2020;31(4):837–851 e810. doi:10.1016/j.cmet.2020.03.003
   PubMed Web of Science ®Google Scholar
• Daien CI, Tan J, Audo R, et al. Gut-derived acetate promotes B10 cells with antiinflammatory effects. JCI Insight. 2021;6(7). doi:10.1172/jci.insight.144156.
   PubMed Web of Science ®Google Scholar
• Sanchez HN, Moroney JB, Gan H, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat Commun. 2020;11(1):60. doi:10.1038/s41467-019-13603-6
   PubMed Web of Science ®Google Scholar
• Kim M, Qie Y, Park J, Kim CH. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe. 2016;20(2):202–214. doi:10.1016/j.chom.2016.07.001
   PubMed Web of Science ®Google Scholar
• Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652–2664. doi:10.1056/NEJMra2002697
   PubMed Web of Science ®Google Scholar
• Takahashi K, Nishida A, Fujimoto T, et al. Reduced abundance of butyrate-producing bacteria species in the Fecal microbial community in Crohn’s disease. Digestion. 2016;93(1):59–65. doi:10.1159/000441768
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275–1283. doi:10.1136/gutjnl-2013-304833
   PubMed Web of Science ®Google Scholar
• Sauer J, Richter KK, Pool-Zobel BL. Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem. 2007;18(11):736–745. doi:10.1016/j.jnutbio.2006.12.012
   PubMed Web of Science ®Google Scholar
• Silva JPB, Navegantes-Lima KC, Oliveira ALB, et al. Protective mechanisms of butyrate on inflammatory bowel disease. Curr Pharm Des. 2018;24(35):4154–4166. doi:10.2174/1381612824666181001153605
   PubMed Web of Science ®Google Scholar
• Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1980;2(8197):712–715. doi:10.1016/S0140-6736(80)91934-0
   PubMed Web of Science ®Google Scholar
• Singh B, Halestrap AP, Paraskeva C. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis. 1997;18(6):1265–1270. doi:10.1093/carcin/18.6.1265
   PubMed Web of Science ®Google Scholar
• Rosignoli P, Fabiani R, De Bartolomeo A, et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis. 2001;22(10):1675–1680. doi:10.1093/carcin/22.10.1675
   PubMed Web of Science ®Google Scholar
• Abrahamse SL, Pool-Zobel BL, Rechkemmer G. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis. 1999;20(4):629–634. doi:10.1093/carcin/20.4.629
   PubMed Web of Science ®Google Scholar
• Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr. 2009;155(3):421–426. doi:10.1016/j.jpeds.2009.03.017
   PubMed Web of Science ®Google Scholar
• Gao Y, Davis B, Zhu W, Zheng N, Meng D, Walker WA. Short-chain fatty acid butyrate, a breast milk metabolite, enhances immature intestinal barrier function genes in response to inflammation in vitro and in vivo. Am J Physiol Gastrointest Liver Physiol. 2021;320(4):G521–G530. doi:10.1152/ajpgi.00279.2020
   PubMed Web of Science ®Google Scholar
• Guo H, Callaway JB, Ting JPY. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:10.1038/nm.3893
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276. doi:10.3389/fimmu.2019.00276
   PubMed Web of Science ®Google Scholar
• Luzardo-Ocampo I, Loarca-Pina G, Gonzalez de Mejia E. Gallic and butyric acids modulated NLRP3 inflammasome markers in a co-culture model of intestinal inflammation. Food Chem Toxicol. 2020;146:111835. doi:10.1016/j.fct.2020.111835
   PubMed Web of Science ®Google Scholar
• Bocker U, Nebe T, Herweck F, et al. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol. 2003;131(1):53–60. doi:10.1046/j.1365-2249.2003.02056.x
   PubMed Web of Science ®Google Scholar
• Chen J, Vitetta L. Butyrate in inflammatory bowel disease therapy. Gastroenterology. 2020;158(5):1511. doi:10.1053/j.gastro.2019.08.064
   PubMed Web of Science ®Google Scholar
• Geirnaert A, Calatayud M, Grootaert C, et al. Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci Rep. 2017;7(1):11450. doi:10.1038/s41598-017-11734-8
   PubMed Web of Science ®Google Scholar
• Luzardo-Ocampo I, Campos-Vega R, Gonzalez de Mejia E, Loarca-Piña G. Consumption of a baked corn and bean snack reduced chronic colitis inflammation in CD-1 mice via downregulation of IL-1 receptor, TLR, and TNF-α associated pathways. Food Res Int. 2020;132:109097. doi:10.1016/j.foodres.2020.109097
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis. Science. 2013;341(6145):569–573. doi:10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhou Q, Dorfman RG, et al. Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats. BMC Gastroenterol. 2016;16(1):84. doi:10.1186/s12876-016-0500-x
   PubMedGoogle Scholar
• Venkatraman A, Ramakrishna BS, Pulimood AB, Patra S, Murthy S. Increased permeability in dextran sulphate colitis in rats: time course of development and effect of butyrate. Scand J Gastroenterol. 2000;35(10):1053–1059. doi:10.1080/003655200451171
   PubMed Web of Science ®Google Scholar
• Zhang T, Ding C, Zhao M, et al. Sodium butyrate reduces colitogenic immunoglobulin A-coated bacteria and modifies the composition of microbiota in IL-10 deficient mice. Nutrients. 2016;8(12):728. doi:10.3390/nu8120728
   PubMed Web of Science ®Google Scholar
• Butzner JD, Parmar R, Bell CJ, Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut. 1996;38(4):568–573. doi:10.1136/gut.38.4.568
   PubMed Web of Science ®Google Scholar
• Bloemen JG, Schreinemacher MH, de Bruine AP, Buurman WA, Bouvy ND, Dejong CH. Butyrate enemas improve intestinal anastomotic strength in a rat model. Dis Colon Rectum. 2010;53(7):1069–1075. doi:10.1007/DCR.0b013e3181d881b7
   PubMed Web of Science ®Google Scholar
• Mishiro T, Kusunoki R, Otani A, et al. Butyric acid attenuates intestinal inflammation in murine DSS-induced colitis model via milk fat globule-EGF factor 8. Lab Investig. 2013;93(7):834–843. doi:10.1038/labinvest.2013.70
   PubMed Web of Science ®Google Scholar
• Burrello C, Giuffre MR, Macandog AD, et al. Fecal microbiota transplantation controls murine chronic intestinal inflammation by modulating immune cell functions and gut microbiota composition. Cells. 2019;8(6):517. doi:10.3390/cells8060517
   PubMed Web of Science ®Google Scholar
• Wen X, Wang HG, Zhang MN, Zhang MH, Wang H, Yang XZ. Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation. World J Gastroenterol. 2021;27(21):2834–2849. doi:10.3748/wjg.v27.i21.2834
   PubMed Web of Science ®Google Scholar
• Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992;103(1):51–56. doi:10.1016/0016-5085(92)91094-K
   PubMed Web of Science ®Google Scholar
• Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther. 1996;10(5):729–736. doi:10.1046/j.1365-2036.1996.d01-509.x
   PubMed Web of Science ®Google Scholar
• Breuer RI, Soergel KH, Ba L, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut. 1997;40(4):485–491. doi:10.1136/gut.40.4.485
   PubMed Web of Science ®Google Scholar
• Hamer HM, Jonkers DM, Vanhoutvin SA, et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr. 2010;29(6):738–744. doi:10.1016/j.clnu.2010.04.002
   PubMed Web of Science ®Google Scholar
• Jamka M, Kokot M, Kaczmarek N, Bermagambetova S, Nowak JK, Walkowiak J. The effect of sodium butyrate enemas compared with placebo on disease activity, endoscopic scores, and histological and inflammatory parameters in inflammatory bowel diseases: a systematic review of randomised controlled trials. Complement Med Res. 2020;28(4):1–13.
   PubMed Web of Science ®Google Scholar
• Vernero M, De Blasio F, Ribaldone DG, et al. The usefulness of microencapsulated sodium butyrate add-on therapy in maintaining remission in patients with ulcerative colitis: a prospective observational study. J Clin Med. 2020;9(12):3941. doi:10.3390/jcm9123941
   PubMed Web of Science ®Google Scholar
• Tominaga K, Kamimura K, Takahashi K, Yokoyama J, Yamagiwa S, Terai S. Diversion colitis and pouchitis: a mini-review. World J Gastroenterol. 2018;24(16):1734–1747. doi:10.3748/wjg.v24.i16.1734
   PubMed Web of Science ®Google Scholar
• Luceri C, Femia AP, Fazi M, et al. Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: a randomized trial. Dig Liver Dis. 2016;48(1):27–33. doi:10.1016/j.dld.2015.09.005
   PubMedGoogle Scholar
• Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Escher J, Hébuterne X, et al. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020;39(3):632–653. doi:10.1016/j.clnu.2019.11.002
   PubMed Web of Science ®Google Scholar
• Akutko K, Stawarski A. Probiotics, prebiotics and synbiotics in inflammatory bowel diseases. J Clin Med. 2021;10(11):2466. doi:10.3390/jcm10112466
   PubMed Web of Science ®Google Scholar
• Fehily SR, Basnayake C, Wright EK, Kamm MA. Fecal microbiota transplantation therapy in Crohn’s disease: systematic review. J Gastroenterol Hepatol. 2021;36(10):2672–2686. doi:10.1111/jgh.15598
   PubMed Web of Science ®Google Scholar
• Imdad A, Nicholson MR, Tanner-Smith EE, et al. Fecal transplantation for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2018;11:Cd012774.
   PubMedGoogle Scholar
• Narula N, Kassam Z, Yuan Y, et al. Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm Bowel Dis. 2017;23(10):1702–1709. doi:10.1097/MIB.0000000000001228
   PubMed Web of Science ®Google Scholar
• Yusuf F, Adewiah S, Fatchiyah F. The level short chain fatty acids and HSP 70 in colorectal cancer and non-colorectal cancer. Acta Inform Med. 2018;26(2):160–163. doi:10.5455/aim.2018.26.160-163
   PubMedGoogle Scholar
• Sengupta S, Muir JG, Gibson PR. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol. 2006;21(1):209–218. doi:10.1111/j.1440-1746.2006.04213.x
   PubMed Web of Science ®Google Scholar
• D’Argenio G, Cosenza V, Delle Cave M, et al. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology. 1996;110(6):1727–1734. doi:10.1053/gast.1996.v110.pm8964397
   PubMed Web of Science ®Google Scholar
• Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer. 1993;55(3):498–505. doi:10.1002/ijc.2910550329
   PubMed Web of Science ®Google Scholar
• Yu DCW, Waby JS, Chirakkal H, Staton CA, Corfe BM. Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer. 2010;9(1):276. doi:10.1186/1476-4598-9-276
   PubMedGoogle Scholar
• Zuo L, Lu M, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol. 2013;62:892–900. doi:10.1016/j.fct.2013.10.028
   PubMed Web of Science ®Google Scholar
• Lazarova DL, Chiaro C, Bordonaro M. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells. BMC Res Notes. 2014;7(1):226. doi:10.1186/1756-0500-7-226
   PubMedGoogle Scholar
• Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–999. doi:10.1016/j.cell.2017.05.016
   PubMed Web of Science ®Google Scholar
• Han R, Sun Q, Wu J, Zheng P, Zhao G. Sodium butyrate upregulates miR-203 expression to exert anti-proliferation effect on colorectal cancer cells. Cell Physiol Biochem. 2016;39(5):1919–1929. doi:10.1159/000447889
   PubMedGoogle Scholar
• Hu S, Liu L, Chang EB, Wang JY, Raufman JP. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Mol Cancer. 2015;14(1):180. doi:10.1186/s12943-015-0450-x
   PubMedGoogle Scholar
• Song M, Wu K, Meyerhardt JA, et al. Fiber intake and survival after colorectal cancer diagnosis. JAMA Oncol. 2018;4(1):71–79. doi:10.1001/jamaoncol.2017.3684
   PubMed Web of Science ®Google Scholar
• Alberts DS, Ritenbaugh C, Story JA, et al. Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps. J Natl Cancer Inst. 1996;88(2):81–92. doi:10.1093/jnci/88.2.81
   PubMed Web of Science ®Google Scholar
• Papadimitriou N, Markozannes G, Kanellopoulou A, et al. An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 2021;12(1):4579. doi:10.1038/s41467-021-24861-8
   PubMed Web of Science ®Google Scholar
• Veettil SK, Wong TY, Loo YS, et al. Role of diet in colorectal cancer incidence: umbrella review of meta-analyses of prospective observational studies. JAMA Netw Open. 2021;4(2):e2037341–e2037341. doi:10.1001/jamanetworkopen.2020.37341
   PubMed Web of Science ®Google Scholar
• Kim YI. AGA technical review: impact of dietary fiber on colon cancer occurrence. Gastroenterology. 2000;118(6):1235–1257. doi:10.1016/S0016-5085(00)70377-5
   PubMed Web of Science ®Google Scholar
• Hajjar R, Richard CS, Santos MM. The role of butyrate in surgical and oncological outcomes in colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2021;320(4):G601–G608. doi:10.1152/ajpgi.00316.2020
   PubMed Web of Science ®Google Scholar
• Cleveland Clinic Center for Medical Art and Photography. Available from: https://my.clevelandclinic.org/
   Google Scholar